Dr. Alice Gottlieb, a renowned expert in the treatment of difficult psoriasis and other hard-to-treat conditions, has joined Hudson Dermatology as director of our new Complex Medical Dermatology unit. Her primary focus is on patients with complicated psoriasis, psoriatic arthritis, hidradenitis suppurativa and dermatitis.
Dr. Gottlieb pioneered the use of biologics for the treatment of psoriasis. She was the first person to demonstrate that monotherapy with TNF inhibitors cleared psoriasis. This single paper, published in the medical journal The Lancet in 2001, revolutionized the field, and she has been involved in biologics development ever since.
Dr. Gottlieb is available for consultations with patients over two years old with complex medical dermatology problems that may benefit from systemic therapy. As an investigator for several novel biologic and small-molecule therapeutics, Dr. Gottlieb will also bring those options to patients who could potentially benefit from them. She is practicing in our Somers office.
Dr. Gottlieb has educated dermatologists worldwide in taking care of psoriatic arthritis, the major condition accompanying psoriasis. Most recently, she founded the nonprofit organization IDEOM, International Dermatology Outcome Measures, which has generated guidelines for clinical trials in psoriasis and hidradenitis suppurativa and is now working on developing practical outcome measures for the dermatology community.
From 2006 to 2016, Dr. Gottlieb served as Chair of Dermatology at the Tufts Medical Center. She obtained her M.D. from Cornell and her Ph.D. in immunology from the Rockefeller University, where she was one of the first women admitted to the M.D.-Ph.D. program. This was followed by a residency in internal medicine at Cornell, a fellowship in rheumatology at the Hospital for Special Surgery and a dermatology residency at Cornell.
If you suffer from hard-to-treat psoriasis or a related condition, Dr. Gottlieb is here to help. Please contact our Somers office at (914) 617-8950 for an appointment or more information.